Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis

Annals of Nutrition and Metabolism

Volumn 55, Issue 4, 2009, Pages 309-316

  Elshamaa, Manal F ^a   Sabry, Samar ^b   Nabih, Mohamed ^b   Elghoroury, Eman A ^a   El Saaid, Gamila S ^a   Ismail, Amany A G ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Hemodialysis; High sensitivity C reactive protein; Lipid peroxidation product; Total antioxidant capacity

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HEMOGLOBIN; HIGH SENSITIVITY C REACTIVE PROTEIN; MALONALDEHYDE; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; UREA; URIC ACID;

ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HIGH SENSITIVITY C REACTIVE PROTEIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; LIPID PEROXIDATION; MALE; MALONALDEHYDE BLOOD LEVEL; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCHOOL CHILD; TOTAL ANTIOXIDANT CAPACITY; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADOLESCENT; ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RENAL DIALYSIS; RISK FACTORS;

EID: 70349892590     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000245938     Document Type: Article

References (42)

1. Dirican M, Sarandol E, Serdar Z, Ocak N, Dilek K: Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis. Clin Nephrol 2007; 68: 144-150.
2. Samouilidou E, Grapsa E, Karpouza A, Lagouranis A: Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis. Blood Purif 2007; 25: 175-178.
3. Antolini F, Valente F, Ricciardi D, Baroni M, Fagugli RM: Principal component analysis of some oxidative stress parameters and their relationships in hemodialytic and transplanted patients. Clin Chim Acta 2005; 358: 87-94.
4. Lucchi L, Iannone A, Bergamini S, Stipo L, Perrone S, Uggeri S, Gatti V, Ferrari F, Tomasi A, Albertazzi A: Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis. Artif Organs 2005; 29: 832-837.
5. Morena M, Crisol JP, Canaud B: Why hemodialysis patients are in prooxidant staté What could be done to correct the pro/antioxidant imbalancé Blood Purif 2000; 18: 191-199.
6. Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy S, Jialal I: Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 2000; 150: 217-224.
7. Nguyen-Khoa T, Massy ZA, de Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M: Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001; 16: 335-340.
8. Kaysen GA: Inflammation and oxidative stress in end-stage renal disease. Adv Nephrol Necker Hosp 2000; 30: 201-214.
9. Mimic-Oka J, Simic T, Djukanovic L, Reljic Z, Davicevic Z: Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol 1999; 51: 233-241.
10. Donica H: Evaluation of lipids peroxidation products vs. proinflammatory cytokines in hemodialyzed patients. Ren Fail 2001; 23: 231-238.
11. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM: Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol 2008; 28: 397-404.
12. Ortega O, Rodriguez I, Gallar P, Carreno A, Ortiz M, Espejo B, Jimenez J, Gutierrez M, Oliet A, Vigil A: Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant 2002; 17: 1105-1109.
13. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. Am J Soc Nephrol 1998; 9 (suppl):16-23.
14. Spittle MA, Hoenich NA, Handelman GI, Hamel P, Levin NW: Oxidative stress and inflammation in hemodialysis patients. Am J Kidney 2001; 38: 1408-1413.
15. Panichi V, Migliori M, de Pietro S, et al: Creactive protein as a marker for chronic inflammation in hemodialysis patients. Blood Purif 2000; 18: 183-190.
16. Boenisch O, Ehmke KD, Heddergoff A, Naoum C, Frel U, Schindler R: C-reactiveprotein and cytokine plasma levels in haemodialysis patients. J Nephrol 2002; 15: 547-551.
17. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in haemodialysis. Kidney Int 1999; 55: 648-658.
18. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volumeKt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213.
19. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V: Method for the measurement of antioxidants. J Clin Pathol 2001; 54: 356-361.
20. Draper HH, Hadley N: Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol 1990; 186: 421-431.
21. Duclos TW: Function of CRP. Ann Med 2000; 32: 274-278.
22. Stompor T, Pasowicz M, Sułowicz W, Dembíska-Kié A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E: An association between coronary artery calcification score, lipid profile and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 2003; 41: 203-211.
23. Abdel-Naeem NM, Kandell NF, El-Shamaa AA, Harba TM, Abdel-Hady AA: Biocompatible dialysis membranes and oxidative stress in patients with end-stage renal disease on maintenance haemodialysis. J Egypt Soc Parasitol 2005; 35(suppl 3):1173-1197.
24. Usberti M, Gerardi GM, Gazzotti RM, Benedini S, Archetti S, Sugherini L, Valentini M, Tira P, Bufano G, Albertini A, di Lorenzo D: Oxidative stress and cardiovascular disease in dialyzed patients. Nephron 2002; 91: 25-33.
25. Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B: Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol 2003; 35: 393-397.
26. Jackson P, Loughrey C, Lightbody J, McNamee P, Young I: Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-1138.
27. Samouilidou E, Grapsa E: Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure. Blood Purif 2003; 21: 209-212.
28. Descamps-Latscha B, Goldfarb B, Nguyen AT, Landais P, London G, Haeffner-Cavaillon N, Jacquot C, Herbelin A, Kazatchkine M: Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialysed patients: a randomized prospective study. Nephron 1991; 59: 279-285.
29. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA: Transcription not synthesis of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85-93. (Pubitemid 20023771)
30. Owen WF, Lowrie EG: C-reactive protein as an outcome predictor for maintenance haemodialysis patients. Kidney Int 1998; 54: 627-636.
31. Mircescu G, Capu C, Stoian I, Vargolici B, Barbulescu C, Ursea N: Global assessment of serum antioxidant status in hemodialysis patients. J Nephrol 2005; 18: 599-605.
32. Malliaraki N, Mpliamplias D, Kampa M, Perakis K, Margioris AN, Castanas E: Total and corrected antioxidant capacity in hemodialyzed patients. BMC Nephrol 2003; 4: 1-4.
33. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A: Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif Organs 2005; 29: 67-72.
34. Zachee P, Emonds MP, Goossens W, Saelemans R, Lims RL, Boogaerts MA: Erythrocyte deformability and oxidative sensitivity in hemodialysis patients. Clin Hemorheol 1988; 8: 439-443.
35. Lewis NP, Macdougall IC, Willis N, Henderson AH: The ventilatory cost of exercise compared in chronic heart failure and chronic renal anaemia. Q J Med 1992; 83: 523-531.
36. Linas SL, Whittenburg D, Repine JH: Role of xanthine oxidase in ischemia/reperfusion injury. Am J Physiol 1990; 258:F711-F716.
37. Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, Guth PH, Kaplowitz N: Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 1992; 262:G669-G676.
38. Costagliola C, Romano L, Sorice P, di Benedetto A: Anemia and chronic renal failure: the possible role of the oxidative state of glutathione. Nephron 1989; 52: 11-14.
39. Korevaar JC, van Manen JG, Dekker FW, de Waart DR, Boeschoten EW, Krediet RT: Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol 2004; 15: 2916-2922.
40. Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Shieh CC, Chen MF: Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care 2006; 10:R36.
41. Carluccio F, Siems W, Stefanelli G, Sommerburg O, Grune T, Riedel E, Hampl H: Homocysteine in chronic renal failure in relation to renal anemia and to oxidative stress parameters 4-hydroxynonenal and malondialdehyde. Clin Nephrol 2002; 58(suppl 1):S26-S30.
42. Antoniadi G, EleftheriadisT, Liakopoulos V, Kakasi E, Kartsios C, Passadakis P, Vargemezis V: Effect of one-year oralα -tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther Apher Dial 2008; 12: 237-242.